Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835
Books209
All textbooksMedical textbooksHuman anatomyOrganisms & biodiversityOther sciences
Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›Cognitive–behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT›References

Continue where you left off ()

GO BEYOND THE PAGEReading is just the beginning.

Turn scientific reading into research. Compare studies, examine evidence, and organize your findings in EvidenceHelix Workspace.

Explore Research Workspace →

Cognitive–behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT · References

References

CC BY 4.0 · NIHR Journals Library · approximately 20 min read

  1. Goldstein LH, Chalder T, Chigwedere C, Khondoker MR, Moriarty J, Toone BK, Mellers JD. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology 2010;74:1986–94. 10.1212/WNL.0b013e3181e3965820548043
  2. Duncan R, Razvi S, Mulhern S. Newly presenting psychogenic nonepileptic seizures: incidence, population characteristics, and early outcome from a prospective audit of a first seizure clinic. Epilepsy Behav 2011;20:308–11. 10.1016/j.yebeh.2010.10.02221195031
  3. Lesser RP. Psychogenic seizures. Neurology 1996;46:1499–507. 10.1212/WNL.46.6.14998649537
  4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. Washington, DC: American Psychiatric Association; 2013. 10.1176/appi.books.9780890425596
  5. World Health Organization. ICD 11 for Mortality and Morbidity Statistics (ICD 11 MMS). Geneva: World Health Organization; 2018.
  6. Scull DA. Pseudoseizures or non-epileptic seizures (NES); 15 synonyms. J Neurol Neurosurg Psychiatry 1997;62:200. 10.1136/jnnp.62.2.200-a
  7. Stone J, Campbell K, Sharma N, Carson A, Warlow CP, Sharpe M. What should we call pseudoseizures? The patient’s perspective. Seizure 2003;12:568–72. 10.1016/S1059-1311(03)00055-414630495
  8. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Description and Diagnostic Guidelines. Geneva: World Health Organization; 1992.
  9. Benbadis SR, Hauser WA. An estimate of the prevalence of psychogenic non-epileptic seizures. Seizure 2000;9:280–1. 10.1053/seiz.2000.040910880289
  10. Kanemoto K, LaFrance WC Jr, Duncan R, Gigineishvili D, Park SP, Tadokoro Y, et al. PNES around the world: where we are now and how we can close the diagnosis and treatment gaps-an ILAE PNES Task Force report. Epilepsia Open 2017;2:307–16. 10.1002/epi4.12060 [Erratum published in Epilepsia Open 2019;4:219.]29588959
  11. Gates JR. Nonepileptic seizures: Classification, coexistence with epilepsy, diagnosis, therapeutic approaches, and consensus. Epilepsy Behav 2002;3:28–33. 10.1006/ebeh.2001.0310
  12. Asadi-Pooya AA, Sperling MR. Epidemiology of psychogenic nonepileptic seizures. Epilepsy Behav 2015;46:60–5. 10.1016/j.yebeh.2015.03.01525882323
  13. Acar G, Salinsky MC. Demographic and historical backgrounds of the elderly with nonepileptic seizures: a comparative study. Neurol India 2010;58:48–52. 10.4103/0028-3886.6039620228463
  14. Duncan R, Oto M, Martin E, Pelosi A. Late onset psychogenic nonepileptic attacks. Neurology 2006;66:1644–7. 10.1212/01.wnl.0000223320.94812.7a16769934
  15. Patel H, Scott E, Dunn D, Garg B. Nonepileptic seizures in children. Epilepsia 2007;48:2086–92. 10.1111/j.1528-1167.2007.01200.x17645540
  16. Angus-Leppan H. Diagnosing epilepsy in neurology clinics: a prospective study. Seizure 2008;17:431–6. 10.1016/j.seizure.2007.12.01018282726
  17. LaFrance WC Jr, Baker GA, Duncan R, Goldstein LH, Reuber M. Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force. Epilepsia 2013;54:2005–18. 10.1111/epi.1235624111933
  18. Mellers JDC. The approach to patients with ‘non-epileptic seizures’. Postgrad Med J 2005;81:498–504. 10.1136/pgmj.2004.02978516085740
  19. Kutlubaev MA, Xu Y, Hackett ML, Stone J. Dual diagnosis of epilepsy and psychogenic nonepileptic seizures: systematic review and meta-analysis of frequency, correlates, and outcomes. Epilepsy Behav 2018;89:70–8. 10.1016/j.yebeh.2018.10.01030384103
  20. McKenzie PS, Oto M, Graham CD, Duncan R. Do patients whose psychogenic non-epileptic seizures resolve, ‘replace’ them with other medically unexplained symptoms? Medically unexplained symptoms arising after a diagnosis of psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry 2011;82:967–9. 10.1136/jnnp.2010.23188621421771
  21. Bermeo-Ovalle A, Kanner AM. Comorbidities in Psychogenic Nonepileptic Seizures: Depressive, Anxiety and Personality Disorders. In LaFrance WC Jr, Schachter SC, editors. Gates and Rowan’s Nonepileptic Seizures. 4th edn. Cambridge: Cambridge University Press; 2018. pp. 245–56. 10.1017/9781316275450.024
  22. Brown RJ, Reuber M. Psychological and psychiatric aspects of psychogenic non-epileptic seizures (PNES): a systematic review. Clin Psychol Rev 2016;45:157–82. 10.1016/j.cpr.2016.01.00327084446
  23. Walsh S, Levita L, Reuber M. Comorbid depression and associated factors in PNES versus epilepsy: systematic review and meta-analysis. Seizure 2018;60:44–56. 10.1016/j.seizure.2018.05.01429906707
  24. Frances PL, Baker GA, Appleton PL. Stress and avoidance in pseudoseizures: testing the assumptions. Epilepsy Res 1999;34:241–9. 10.1016/S0920-1211(98)00116-810210039
  25. Goldstein LH, Drew C, Mellers J, Mitchell-O’Malley S, Oakley DA. Dissociation, hypnotizability, coping styles and health locus of control: characteristics of pseudoseizure patients. Seizure 2000;9:314–22. 10.1053/seiz.2000.042110933985
  26. Duncan R, Oto M, Wainman-Lefley J. Mortality in a cohort of patients with psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry 2012;83:761–2. 10.1136/jnnp-2012-30290022665451
  27. Ludwig L, Pasman JA, Nicholson T, Aybek S, David AS, Tuck S, et al. Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies. Lancet Psychiatry 2018;5:307–20. 10.1016/S2215-0366(18)30051-829526521
  28. Pick S, Mellers JD, Goldstein LH. Dissociation in patients with dissociative seizures: relationships with trauma and seizure symptoms. Psychol Med 2017;47:1215–29. 10.1017/S003329171600309328065191
  29. Fiszman A, Alves-Leon SV, Nunes RG, D’Andrea I, Figueira I. Traumatic events and posttraumatic stress disorder in patients with psychogenic nonepileptic seizures: a critical review. Epilepsy Behav 2004;5:818–25. 10.1016/j.yebeh.2004.09.00215582828
  30. Beghi M, Cornaggia I, Magaudda A, Perin C, Peroni F, Cornaggia CM. Childhood trauma and psychogenic nonepileptic seizures: a review of findings with speculations on the underlying mechanisms. Epilepsy Behav 2015;52:169–73. 10.1016/j.yebeh.2015.09.00726432009
  31. Reuber M, Howlett S, Khan A, Grünewald RA. Non-epileptic seizures and other functional neurological symptoms: predisposing, precipitating, and perpetuating factors. Psychosomatics 2007;48:230–8. 10.1176/appi.psy.48.3.23017478592
  32. Leserman J. Sexual abuse history: prevalence, health effects, mediators, and psychological treatment. Psychosom Med 2005;67:906–15. 10.1097/01.psy.0000188405.54425.2016314595
  33. Sharpe D, Faye C. Non-epileptic seizures and child sexual abuse: a critical review of the literature. Clin Psychol Rev 2006;26:1020–40. 10.1016/j.cpr.2005.11.01116472897
  34. Binzer M, Stone J, Sharpe M. Recent onset pseudoseizures – clues to aetiology. Seizure 2004;13:146–55. 10.1016/S1059-1311(03)00184-515010051
  35. Stone J, Sharpe M, Binzer M. Motor conversion symptoms and pseudoseizures: a comparison of clinical characteristics. Psychosomatics 2004;45:492–9. 10.1176/appi.psy.45.6.49215546826
  36. Moore PM, Baker GA, McDade G, Chadwick D, Brown S. Epilepsy, pseudoseizures and perceived family characteristics: a controlled study. Epilepsy Res 1994;18:75–83. 10.1016/0920-1211(94)90035-38088259
  37. Krawetz P, Fleisher W, Pillay N, Staley D, Arnett J, Maher J. Family functioning in subjects with pseudoseizures and epilepsy. J Nerv Ment Dis 2001;189:38–43. 10.1097/00005053-200101000-0000711206663
  38. Wood BL, McDaniel S, Burchfiel K, Erba G. Factors distinguishing families of patients with psychogenic seizures from families of patients with epilepsy. Epilepsia 1998;39:432–7. 10.1111/j.1528-1157.1998.tb01396.x9578034
  39. Al Marzooqi SM, Baker GA, Reilly J, Salmon P. The perceived health status of people with psychologically derived non-epileptic attack disorder and epilepsy: a comparative study. Seizure 2004;13:71–5. 10.1016/S1059-1311(03)00158-415129833
  40. Jones B, Reuber M, Norman P. Correlates of health-related quality of life in adults with psychogenic nonepileptic seizures: a systematic review. Epilepsia 2016;57:171–81. 10.1111/epi.1326826701628
  41. Cullingham T, Kirkby A, Sellwood W, Eccles FJR. Avoidance in nonepileptic attack disorder: a systematic review and meta-analyses. Epilepsy Behav 2019;95:100–11. 10.1016/j.yebeh.2019.03.00431030077
  42. Dimaro LV, Dawson DL, Roberts NA, Brown I, Moghaddam NG, Reuber M. Anxiety and avoidance in psychogenic nonepileptic seizures: the role of implicit and explicit anxiety. Epilepsy Behav 2014;33:77–86. 10.1016/j.yebeh.2014.02.01624632427
  43. Goldstein LH, Mellers JD. Ictal symptoms of anxiety, avoidance behaviour, and dissociation in patients with dissociative seizures. J Neurol Neurosurg Psychiatry 2006;77:616–21. 10.1136/jnnp.2005.06687816614021
  44. Robson C, Myers L, Pretorius C, Lian OS, Reuber M. Health related quality of life of people with non-epileptic seizures: the role of socio-demographic characteristics and stigma. Seizure 2018;55:93–9. 10.1016/j.seizure.2018.01.00129414141
  45. Fairclough G, Fox J, Mercer G, Reuber M, Brown RJ. Understanding the perceived treatment needs of patients with psychogenic nonepileptic seizures. Epilepsy Behav 2014;31:295–303. 10.1016/j.yebeh.2013.10.02524239434
  46. Karterud HN, Haavet OR, Risor MB. Social participation in young people with nonepileptic seizures (NES): a qualitative study of managing legitimacy in everyday life. Epilepsy Behav 2016;57:23–8. 10.1016/j.yebeh.2016.01.00926921594
  47. LaFrance WC Jr, Alosco ML, Davis JD, Tremont G, Ryan CE, Keitner GI, et al. Impact of family functioning on quality of life in patients with psychogenic nonepileptic seizures versus epilepsy. Epilepsia 2011;52:292–300. 10.1111/j.1528-1167.2010.02765.x21299547
  48. Lempert T, Schmidt D. Natural history and outcome of psychogenic seizures: a clinical study in 50 patients. J Neurol 1990;237:35–8. 10.1007/BF003196652319265
  49. Reuber M, Pukrop R, Bauer J, Helmstaedter C, Tessendorf N, Elger CE. Outcome in psychogenic nonepileptic seizures: 1 to 10-year follow-up in 164 patients. Ann Neurol 2003;53:305–11. 10.1002/ana.300012601698
  50. Quigg M, Armstrong RF, Farace E, Fountain NB. Quality of life outcome is associated with cessation rather than reduction of psychogenic nonepileptic seizures. Epilepsy Behav 2002;3:455–9. 10.1016/S1525-5050(02)00524-312609268
  51. Martin RC, Bell B, Hermann B, Mennemeyer S. Nonepileptic Seizures and their Costs: The Role of Neuropsychology. In Prigatano GP, Pliskin NH, editors. Clinical Neuropsychology and Cost Outcome Research: A Beginning. New York, NY: Psychology Press; 2003. pp. 235–58. 10.4324/9781315787039-17
  52. Reuber M, Mitchell AJ, Howlett S, Elger CE. Measuring outcome in psychogenic nonepileptic seizures: how relevant is seizure remission? Epilepsia 2005;46:1788–95. 10.1111/j.1528-1167.2005.00280.x16302859
  53. Walczak TS, Papacostas S, Williams DT, Scheuer ML, Lebowitz N, Notarfrancesco A. Outcome after diagnosis of psychogenic nonepileptic seizures. Epilepsia 1995;36:1131–7. 10.1111/j.1528-1157.1995.tb00472.x7588458
  54. Selwa LM, Geyer J, Nikakhtar N, Brown MB, Schuh LA, Drury I. Nonepileptic seizure outcome varies by type of spell and duration of illness. Epilepsia 2000;41:1330–4. 10.1111/j.1528-1157.2000.tb04613.x11051130
  55. Asadi-Pooya AA, Bahrami Z, Homayoun M. Natural history of patients with psychogenic nonepileptic seizures. Seizure 2019;66:22–5. 10.1016/j.seizure.2019.02.00630772644
  56. McKenzie P, Oto M, Russell A, Pelosi A, Duncan R. Early outcomes and predictors in 260 patients with psychogenic nonepileptic attacks. Neurology 2010;74:64–9. 10.1212/WNL.0b013e3181c7da6a20038774
  57. Kanner AM, Parra J, Frey M, Stebbins G, Pierre-Louis S, Iriarte J. Psychiatric and neurologic predictors of psychogenic pseudoseizure outcome. Neurology 1999;53:933–8. 10.1212/wnl.53.5.93310496249
  58. Ettinger AB, Dhoon A, Weisbrot DM, Devinsky O. Predictive factors for outcome of nonepileptic seizures after diagnosis. J Neuropsychiatry Clin Neurosci 1999;11:458–63. 10.1176/jnp.11.4.45810570758
  59. Reuber M, Pukrop R, Bauer J, Derfuss R, Elger CE. Multidimensional assessment of personality in patients with psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry 2004;75:743–8. 10.1136/jnnp.2003.01382115090571
  60. Carton S, Thompson PJ, Duncan JS. Non-epileptic seizures: patients’ understanding and reaction to the diagnosis and impact on outcome. Seizure 2003;12:287–94. 10.1016/S1059-1311(02)00290-X12810341
  61. Arain AM, Hamadani AM, Islam S, Abou-Khalil BW. Predictors of early seizure remission after diagnosis of psychogenic nonepileptic seizures. Epilepsy Behav 2007;11:409–12. 10.1016/j.yebeh.2007.07.01717905668
  62. McDade G, Brown SW. Non-epileptic seizures: management and predictive factors of outcome. Seizure 1992;1:7–10. 10.1016/1059-1311(92)90047-51344323
  63. Krahn LE, Reese MM, Rummans TA, Peterson GC, Suman VJ, Sharbrough FW, Cascino GD. Health care utilization of patients with psychogenic nonepileptic seizures. Psychosomatics 1997;38:535–42. 10.1016/S0033-3182(97)71398-79427850
  64. Martin RC, Gilliam FG, Kilgore M, Faught E, Kuzniecky R. Improved health care resource utilization following video-EEG-confirmed diagnosis of nonepileptic psychogenic seizures. Seizure 1998;7:385–90. 10.1016/S1059-1311(05)80007-X9808114
  65. Magee JA, Burke T, Delanty N, Pender N, Fortune GM. The economic cost of nonepileptic attack disorder in Ireland. Epilepsy Behav 2014;33:45–8. 10.1016/j.yebeh.2014.02.01024632352
  66. Ahmedani BK, Osborne J, Nerenz DR, Haque S, Pietrantoni L, Mahone D, Smith BJ. Diagnosis, costs, and utilization for psychogenic non-epileptic seizures in a US health care setting. Psychosomatics 2013;54:28–34. 10.1016/j.psym.2012.08.00523194931
  67. Razvi S, Mulhern S, Duncan R. Newly diagnosed psychogenic nonepileptic seizures: health care demand prior to and following diagnosis at a first seizure clinic. Epilepsy Behav 2012;23:7–9. 10.1016/j.yebeh.2011.10.00922093246
  68. LaFrance WC Jr, Baird GL, Barry JJ, Blum AS, Frank Webb A, Keitner GI, et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry 2014;71:997–1005. 10.1001/jamapsychiatry.2014.81724989152
  69. LaFrance WC, Keitner GI, Papandonatos GD, Blum AS, Machan JT, Ryan CE, Miller IW. Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures. Neurology 2010;75:1166–73. 10.1212/WNL.0b013e3181f4d5a920739647
  70. Agrawal N, Fleminger S, Ring H, Deb S. Neuropsychiatry in the UK: national survey of existing service provision. Psychiatric Bulletin 2008;32:288–91. 10.1192/pb.bp.107.018424
  71. Mayor R, Smith PE, Reuber M. Management of patients with nonepileptic attack disorder in the United Kingdom: a survey of health care professionals. Epilepsy Behav 2011;21:402–6. 10.1016/j.yebeh.2011.05.01921752718
  72. Howlett S, Reuber M. An augmented model of brief psychodynamic interpersonal therapy for patients with nonepileptic seizures. Psychother Theor Res Pract Train 2009;46:125–38. 10.1037/a0015138
  73. Russell LA, Abbass AA, Allder SJ, Kisely S, Pohlmann-Eden B, Town JM. A pilot study of reduction in healthcare costs following the application of intensive short-term dynamic psychotherapy for psychogenic nonepileptic seizures. Epilepsy Behav 2016;63:17–19. 10.1016/j.yebeh.2016.07.01727541836
  74. Zaroff CM, Myers L, Barr WB, Luciano D, Devinsky O. Group psychoeducation as treatment for psychological nonepileptic seizures. Epilepsy Behav 2004;5:587–92. 10.1016/j.yebeh.2004.03.00515256198
  75. Chen DK, Maheshwari A, Franks R, Trolley GC, Robinson JS, Hrachovy RA. Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia 2014;55:156–66. 10.1111/epi.1248124446955
  76. Wiseman H, Mousa S, Howlett S, Reuber M. A multicenter evaluation of a brief manualized psychoeducation intervention for psychogenic nonepileptic seizures delivered by health professionals with limited experience in psychological treatment. Epilepsy Behav 2016;63:50–6. 10.1016/j.yebeh.2016.07.03327565438
  77. Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med 2007;69:881–8. 10.1097/PSY.0b013e31815b00c418040099
  78. van Dessel N, den Boeft M, van der Wouden JC, Kleinstäuber M, Leone SS, Terluin B, et al. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev 2014;11:CD011142. 10.1002/14651858.CD011142.pub2
  79. Carlson P, Nicholson Perry K. Psychological interventions for psychogenic non-epileptic seizures: a meta-analysis. Seizure 2017;45:142–50. 10.1016/j.seizure.2016.12.00728063373
  80. Martlew J, Pulman J, Marson AG. Psychological and behavioural treatments for adults with non-epileptic attack disorder. Cochrane Database Syst Rev 2014;2:CD006370. 10.1002/14651858.CD006370.pub2
  81. Chalder T. Non epileptic attacks: a cognitive behavioural approach in a single case with a four year follow up. Clin Psychol Psychother 1996;3:291–7. 10.1002/(SICI)1099-0879(199612)3:4<291::AID-CPP72>3.0.CO;2-H
  82. Goldstein LH, Deale AC, Mitchell-O’Malley SJ, Toone BK, Mellers JDC. An evaluation of cognitive behavioral therapy as a treatment for dissociative seizures: a pilot study. Cogn Behav Neurol 2004;17:41–9. 10.1097/00146965-200403000-0000515209224
  83. Goldstein LH, LaFrance WC Jr, Mellers JDC, Chalder T. Cognitive Behavioral Based Treatments for Psychogenic Nonepileptic Seizures. In LaFrance WC Jr, Schachter SC, editors. Gates and Rowan’s Nonepileptic Seizures Cambridge: Cambridge University Press; 2018. pp. 300–9. 10.1017/9781316275450.030
  84. Goldstein LH, Mellers JDC, Landau S, Stone J, Carson A, Medford N, et al. COgnitive behavioural therapy vs standardised medical care for adults with Dissociative non-Epileptic Seizures (CODES): a multicentre randomised controlled trial protocol. BMC Neurol 2015;15:98. 10.1186/s12883-015-0350-026111700
  85. Baird GL, Harlow LL, Machan JT, LaFrance WC Jr. Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy Behav 2017;73:273–9. 10.1016/j.yebeh.2017.04.01528624511
  86. National Institute for Health and Care Excellence (NICE). Epilepsies: Diagnosis and Management. Clinical Guideline [CG137]. London: NICE; 2012.
  87. Scottish Intercollegiate Guidelines Network. Diagnosis and Management of Epilepsy in Adults. Guidelines 70. Edinburgh: Healthcare Improvement Scotland; 2005.
  88. Kerr M, Mensah S, Besag F, De Toffol B, Ettinger A, Kanemoto K, et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 2011:52:2133–8. 10.1111/j.1528-1167.2011.03276.x21955156
  89. LaFrance WC Jr, Alper K, Babcock D, Barry JJ, Benbadis S, Caplan R, et al. Nonepileptic seizures treatment workshop summary. Epilepsy Behav 2006;8:451–61. 10.1016/j.yebeh.2006.02.00416540377
  90. Kelley MS, Jacobs MP, Lowenstein DH, NINDS Epilepsy Benchmark Stewards. The NINDS epilepsy research benchmarks. Epilepsia 2009;50:579–82. 10.1111/j.1528-1167.2008.01813.x19317887
  91. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655. 10.1136/bmj.a165518824488
  92. Robinson EJ, Goldstein LH, McCrone P, Perdue I, Chalder T, Mellers JDC, et al. COgnitive behavioural therapy versus standardised medical care for adults with Dissociative non-Epileptic Seizures (CODES): statistical and economic analysis plan for a randomised controlled trial. Trials 2017;18:258. 10.1186/s13063-017-2006-428587649
  93. Hall-Patch L, Brown R, House A, Howlett S, Kemp S, Lawton G, et al. Acceptability and effectiveness of a strategy for the communication of the diagnosis of psychogenic nonepileptic seizures. Epilepsia 2010;51:70–8. 10.1111/j.1528-1167.2009.02099.x
  94. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
  95. Jones B, de C Williams AC. CBT to reduce healthcare use for medically unexplained symptoms: systematic review and meta-analysis. Br J Gen Pract 2019;69:e262–e269. 10.3399/bjgp19X70127330692089
  96. Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ. Pharmacological interventions for somatoform disorders in adults. Cochrane Database Syst Rev 2014;11:CD010628. 10.1002/14651858.CD010628.pub2
  97. Liu J, Gill NS, Teodorczuk A, Li Z-J, Sun J. The efficacy of cognitive behavioural therapy in somatoform disorders and medically unexplained physical symptoms: a meta-analysis of randomized controlled trials. J Affect Disord 2019;245:98–112. 10.1016/j.jad.2018.10.11430368076
  98. Menon V, Rajan TM, Kuppili PP, Sarkar S. Cognitive behavior therapy for medically unexplained symptoms: a systematic review and meta-analysis of published controlled trials. Indian J Psychol Med 2017;39:399–406. 10.4103/IJPSYM.IJPSYM_17_1728852229
  99. Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med 2007;69:889–900. 10.1097/PSY.0b013e31815b5cf618040100
  100. Pourová M, Klocek A, Řiháček T, Čevelíček M. Therapeutic change mechanisms in adults with medically unexplained physical symptoms: a systematic review. J Psychosom Res 2020;134:110124. 10.1016/j.jpsychores.2020.11012432348898
  101. Brown RJ, Reuber M. Towards an integrative theory of psychogenic non-epileptic seizures (PNES). Clin Psychol Rev 2016;47:55–70. 10.1016/j.cpr.2016.06.00327340856
  102. Lang PJ. Fear Reduction and Fear Behaviour: Problems in Treating a Construct. In Shilen JM, editor. Research in Psychotherapy (Vol III). Washington, DC: American Psychological Association; 1968. pp. 90–102. 10.1037/10546-004
  103. Mowrer OH. Learning Theory and Behaviour. New York, NY: Wiley; 1960. 10.1037/10802-000
  104. Roth AD. A new scale for the assessment of competences in cognitive and behavioural therapy. Behav Cogn Psychother 2016;44:620–4. 10.1017/S135246581600001126898543
  105. Burgess M, Andiappan M, Chalder T. Cognitive behaviour therapy for chronic fatigue syndrome in adults: face to face versus telephone treatment: a randomized controlled trial. Behav Cogn Psychother 2012;40:175–91. 10.1017/S135246581100054321929831
  106. Mohr DC, Vella L, Hart S, Heckman T, Simon G. The effect of telephone-administered psychotherapy on symptoms of depression and attrition: a meta-analysis. Clinical Psychol (New York) 2008;15:243–53. 10.1111/j.1468-2850.2008.00134.x
  107. Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R, Kwan I. Increasing response rates to postal questionnaires: systematic review. BMJ 2002;324:1183. 10.1136/bmj.324.7347.118312016181
  108. Ministries of Housing, Communities and Local Government. English Indices of Deprivation 2010. 2010. URL: www.gov.uk/government/statistics/english-indices-of-deprivation-2010 (accessed 15 March 2019).
  109. Scottish Government. Scottish Index of Multiple Deprivation. 2012. URL: www.gov.scot/Topics/Statistics/SIMD/DataAnalysis/Background-Data-2012/Background2SIMD2012 (accessed 7 January 2019).
  110. Welsh Government. Welsh Index of Multiple Deprivation. 2011. URL: https://gov.wales/statistics-and-research/welsh-index-multiple-deprivation/?tab=previous%26lang=en (accessed 15 March 2019).
  111. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl. 20):22–33.
  112. Germans S, Van Heck GL, Moran P, Hodiamont PPG. The self-report standardized assessment of personality-abbreviated scale: preliminary results of a brief screening test for personality disorders. Personal Ment Health 2008;2:70–6. 10.1002/pmh.34
  113. Cramer JA, Baker GA, Jacoby A. Development of a new seizure severity questionnaire: initial reliability and validity testing. Epilepsy Res 2002;48:187–97. 10.1016/S0920-1211(02)00003-711904237
  114. Ware J, Kosinski M, Keller S. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33. 10.1097/00005650-199603000-000038628042
  115. Cheak-Zamora NC, Wyrwich KW, McBride TD. Reliability and validity of the SF-12v2 in the medical expenditure panel survey. Qual Life Res 2009;18:727–35. 10.1007/s11136-009-9483-119424821
  116. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727–36. 10.1007/s11136-011-9903-x21479777
  117. Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry 2002;180:461–4. 10.1192/bjp.180.5.46111983645
  118. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092–7. 10.1001/archinte.166.10.109216717171
  119. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–13. 10.1046/j.1525-1497.2001.016009606.x11556941
  120. Barkham M, Bewick B, Mullin T, Gilbody S, Connell J, Cahill J, et al. The CORE-10: A short measure of psychological distress for routine use in the psychological therapies. Couns Psychother Res 2013;13:3–13. 10.1080/14733145.2012.729069
  121. Carson AJ, Stone J, Hansen CH, Duncan R, Cavanagh J, Matthews K, et al. Somatic symptom count scores do not identify patients with symptoms unexplained by disease: a prospective cohort study of neurology outpatients. J Neurol Neurosurg Psychiatry 2015;86:295–301. 10.1136/jnnp-2014-30823424935983
  122. Kroenke K, Spitzer RL, deGruy FV III, Swindle R. A symptom checklist to screen for somatoform disorders in primary care. Psychosomatics 1998;39:263–72. 10.1016/S0033-3182(98)71343-X9664773
  123. Spitzer RL, Williams JBW, Kroenke K, Linzer M, deGruy FV III, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994;272:1749–56. 10.1001/jama.1994.035202200430297966923
  124. Lempert T, Dieterich M, Huppert D, Brandt T. Psychogenic disorders in neurology: frequency and clinical spectrum. Acta Neurol Scand 1990;82:335–40. 10.1111/j.1600-0404.1990.tb03312.x2281751
  125. Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976.
  126. Rimes KA, Chalder T. The Beliefs about Emotions Scale: validity, reliability and sensitivity to change. J Psychosom Res 2010;68:285–92. 10.1016/j.jpsychores.2009.09.01420159215
  127. White PD, Goldsmith KA, Johnson AL, Potts L, Walwyn R, DeCesare JC, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 2011;377:823–36. 10.1016/S0140-6736(11)60096-221334061
  128. Sharpe M, Walker J, Williams C, Stone J, Cavanagh J, Murray G, et al. Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology 2011;77:564–72. 10.1212/WNL.0b013e318228c0c721795652
  129. Baldwin SA, Murray DM, Shadish WR, Pals SL, Holland JM, Abramowitz JS, et al. Intraclass correlation associated with therapists: estimates and applications in planning psychotherapy research. Cogn Behav Ther 2011;40:15–33. 10.1080/16506073.2010.52073121337212
  130. Altman DG, Doré CJ. Baseline comparisons in randomized clinical trials. Stat Med 1991;10:797–9. 10.1002/sim.47801005142068432
  131. Little RJA, Rubin DB. Statistical Analysis with Missing Data. 2nd edn. New York, NY: John Wiley & Sons Ltd; 2002. 10.1002/9781119013563
  132. van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 2007;16:219–42. 10.1177/096228020607446317621469
  133. Goldstein LH, Robinson EJ, Reuber M, Chalder T, Callaghan H, Eastwood C, et al. Characteristics of 698 patients with dissociative seizures: a UK multicenter study. Epilepsia 2019;60:2182–93. 10.1111/epi.1635031608436
  134. Goldstein LH, Robinson EJ, Mellers JDC, Stone J, Carson A, Reuber M, et al. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. Lancet Psychiatry 2020;7:491–505. 10.1016/S2215-0366(20)30128-032445688
  135. Wilkinson M, Day E, Purnell J, Pilecka I, Perdue I, Murray J, et al. The experiences of therapists providing cognitive behavioral therapy (CBT) for dissociative seizures in the CODES randomized controlled trial: a qualitative study. Epilepsy Behav 2020;105:106943. 10.1016/j.yebeh.2020.10694332078929
  136. Sloan JA, Cella D, Hays RD. Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol 2005;58:1217–19. 10.1016/j.jclinepi.2005.07.00916291464
  137. Read J, Jordan H, Perdue I, Purnell J, Murray J, Chalder T, et al. The experience of trial participation, treatment approaches and perceptions of change among participants with dissociative seizures within the CODES randomized controlled trial: a qualitative study. Epilepsy Behav 2020;111:107230. 10.1016/j.yebeh.2020.10723032640411
  138. Perez DL, LaFrance WC Jr. Nonepileptic seizures: an updated review. CNS Spectr 2016;21:239–46. 10.1017/S109285291600002X26996600
  139. Fritzsche K, Baumann K, Götz-Trabert K, Schulze-Bonhage A. Dissociative seizures: a challenge for neurologists and psychotherapists. Dtsch Arztebl Int 2013;110:263–8. 10.3238/arztebl.2013.026323667393
  140. Ladha H, Gupta S, Pati S. Trends in hospital inpatient costs of psychogenic nonepileptic seizures (P3.230). Neurology 2017;88:P3.230.
  141. Beecham J, Knapp M. Costing Psychiatric Interventions. In Thornicroft G, editor. Measuring Mental Health Needs. London: Gaskell; 2001. pp. 200–24.
  142. Curtis L, Burns A. Unit Costs of Health and Social Care 2018. Canterbury: Personal Social Services Research Unit, University of Kent; 2018. URL: www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2018/ (accessed 7 April 2021).
  143. Department of Health and Social Care (DHSC). Reference Costs 2017/18: Highlights, Analysis and Introduction to the Data. London: DHSC; 2018. URL: https://improvement.nhs.uk/documents/1972/1_-_Reference_costs_201718.pdf (accessed 7 April 2021).
  144. Office for National Statistics. UK Labour Market: Jan 2017. Estimates of Employment, Unemployment, Economic Inactivity and Other Employment-Related Statistics for the UK. 2017. URL: www.ons.gov.uk/employmentandlabourmarket/peopleinwork/employmentandemployeetypes/bulletins/uklabourmarket/jan2017 (accessed 15 March 2019).
  145. Joint Formulary Committee. British National Formulary. 77 ed. London: BMJ Group and Pharmaceutical Press; 2019.
  146. Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ 2018;27:7–22. 10.1002/hec.356428833869
  147. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005;14:487–96. 10.1002/hec.94415497198
  148. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004;42:851–9. 10.1097/01.mlr.0000135827.18610.0d15319610
  149. Langfitt JT, Vickery BG, McDermott MP, Messing S, Berg AT, Spencer SS, et al. Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy. Qual Life Res 2006;15:899–914. 10.1007/s11136-005-5231-316721649
  150. van Hout B, Janssen MF, Feng Y-S, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012;15:708–15. 10.1016/j.jval.2012.02.00822867780
  151. National Institute for Health and Care Excellence. Position Statement on Use of the EQ-5D-5L Value Set for England. 2019. URL: www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/technology-appraisal-guidance/eq-5d-5l (accessed 13 March 2020).
  152. Jordan H, Feehan S, Perdue I, Murray J, Goldstein LH. Exploring psychiatrists’ perspectives of working with patients with dissociative seizures in the UK healthcare system as part of the CODES trial: a qualitative study. BMJ Open 2019;9:e026493. 10.1136/bmjopen-2018-026493
  153. Rawlings GH, Perdue I, Goldstein LH, Carson AJ, Stone J, Reuber M. Neurologists’ experiences of participating in the CODES study – a multicentre randomised controlled trial comparing cognitive behavioural therapy vs standardised medical care for dissociative seizures. Seizure 2019;71:8–12. 10.1016/j.seizure.2019.05.02031158560
  154. Worsely C, Whitehead K, Kandler R, Reuber M. Illness perceptions of health care workers in relation to epileptic and psychogenic nonepileptic seizures. Epilepsy Behav 2011;20:668–73. 10.1016/j.yebeh.2011.01.02921440511
  155. Hingray C, El-Hage W, Duncan R, Gigineishvili D, Kanemoto K, LaFrance WC Jr, et al. Access to diagnostic and therapeutic facilities for psychogenic nonepileptic seizures: An international survey by the ILAE PNES Task Force. Epilepsia 2018;59:203–14. 10.1111/epi.1395229152734
  156. Kanaan RA, Armstrong D, Wessely SC. Neurologists’ understanding and management of conversion disorder. J Neurol Neurosurg Psychiatry 2011;82:961–6. 10.1136/jnnp.2010.23311421325661
  157. Rawlings GH, Reuber M. What patients say about living with psychogenic nonepileptic seizures: a systematic synthesis of qualitative studies. Seizure 2016;41:100–11. 10.1016/j.seizure.2016.07.01427522576
  158. Karterud HN, Knizek BL, Nakken KO. Changing the diagnosis from epilepsy to PNES: patients’ experiences and understanding of their new diagnosis. Seizure 2010;19:40–6. 10.1016/j.seizure.2009.11.00119963406
  159. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P. Framework for design and evaluation of complex interventions to improve health. BMJ 2000;321:694–6. 10.1136/bmj.321.7262.69410987780
  160. Möhler R, Köpke S, Meyer G. Criteria for Reporting the Development and Evaluation of Complex Interventions in healthcare: revised guideline (CReDECI 2). Trials 2015;16:204. 10.1186/s13063-015-0709-y25935741
  161. Rubin HJ, Rubin IS. Qualitative Interviewing: The Art of Hearing Data. Thousand Oaks, CA: SAGE Publications Ltd; 1995.
  162. Furber C. Framework analysis: a method for analysing qualitative data. Afr J Midwifery Womens Health 2010;4:97–100. 10.12968/ajmw.2010.4.2.47612
  163. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77–101. 10.1191/1478088706qp063oa
  164. Denzin NK. Triangulation: A Case for Methodological Evaluation and Combination. In Sociological Methods. A Sourcebook. New York, NY: MacGraw-Hill; 1978. pp. 339–57.
  165. Patton MQ. Enhancing the quality and credibility of qualitative analysis. Health Serv Res 1999;34:1189–208.10591279
  166. LaFrance WC Jr, Reuber M, Goldstein LH. Management of psychogenic nonepileptic seizures. Epilepsia 2013;54(Suppl. 1):53–67. 10.1111/epi.1210623458467
  167. Dworetzky BA. What are we communicating when we present the diagnosis of PNES? Epilepsy Curr 2015;15:353–7. 10.5698/1535-7511-15.6.35326633963
  168. Sahaya K, Dholakia SA, Lardizabal D, Sahota PK. Opinion survey of health care providers towards psychogenic non epileptic seizures. Clin Neurol Neurosurg 2012;114:1304–7. 10.1016/j.clineuro.2012.03.04722537871
  169. Rawlings GH, Reuber M. Health care practitioners’ perceptions of psychogenic nonepileptic seizures: a systematic review of qualitative and quantitative studies. Epilepsia 2018;59:1109–23. 10.1111/epi.1418929750340
  170. Rommelfanger KS, Factor SA, LaRoche S, Rosen P, Young R, Rapaport MH. Disentangling stigma from functional neurological disorders: conference report and roadmap for the future. Front Neurol 2017;8:106. 10.3389/fneur.2017.0010628424653
  171. Asadi-Pooya AA, Tinker J. Delay in diagnosis of psychogenic nonepileptic seizures in adults: a post hoc study. Epilepsy Behav 2017;75:143–5. 10.1016/j.yebeh.2017.08.00528865250
  172. Reuber M, Fernández G, Bauer J, Helmstaedter C, Elger CE. Diagnostic delay in psychogenic nonepileptic seizures. Neurology 2002;58:493–5. 10.1212/wnl.58.3.49311839862
  173. Mahoney AEJ, Hobbs MJ, Newby JM, Williams AD, Andrews G. Psychometric properties of the worry behaviors inventory: replication and extension in a large clinical and community sample. Behav Cogn Psychother 2018;46:84–100. 10.1017/S135246581700045528756794
  174. Cope SR, Poole N, Agrawal N. Treating functional non-epileptic attacks – should we consider acceptance and commitment therapy? Epilepsy Behav 2017;73:197–203. 10.1016/j.yebeh.2017.06.00328648970
← Overall discussion and conclusionsAcknowledgements →

Attribution. Laura H Goldstein; Emily J Robinson; Izabela Pilecka; Iain Perdue; Iris Mosweu; Julie Read et al. (2021). Cognitive–behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT. NIHR Journals Library. Copyright © 2021 Goldstein et al. This work was produced by Goldstein et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited. Licensed under CC BY 4.0. NCBI Bookshelf NBK571623. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • References

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support